✦ LIBER ✦

Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation

✍ Scribed by Sorin J. Brener; Deepak L. Bhatt; David J. Moliterno; Jakob P. Schneider; Stephen G. Ellis; Eric J. Topol

Book ID: 113440556
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 135 KB
Volume: 92
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2003.08.063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective Anticoagulation by Argatroban

Effective Anticoagulation by Argatroban During Coronary Stent Implantation in a Patient with Heparin-Induced Thrombocytopenia

✍ Shunji Suzuki; Susumu Sakamoto; Masanobu Koide; Miyako Matsuo; Katsura Fujii; Ta 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Report of successful use of argatroban a

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

✍ Lewis, Bruce E. ;Iaffaldano, Robert ;McKiernan, Thomas L. ;Rao, Luxman ;Donkin, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) is a severe complication of heparin caused by an antibody response to the heparin-platelet factor 4 complex which results in severe thrombosis. Heparin rechallenge in HllTS patients carries a high risk of inducing thrombosis. Antithrom

Efficacy and Safety of Unfractionated He

Efficacy and Safety of Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Revascularization for an Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials Performed With Stents and Thienopyridines

✍ David E. Winchester; William D. Brearley; Xuerong Wen; Ki E. Park; Anthony A. Ba 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

A randomized two-by-two comparison of hi

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial

✍ David J. Moliterno;; the TENACITY Steering Committee; Investigators 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views